Pulmonary congestion is an intermediate biomarker and long-term predictor of acute decompensated heart failure.To evaluate the effects of air pollution on pulmonary congestion assessed by lung ultrasound.In a single-center, prospective, observational study design, we enrolled 1292 consecutive patients with chronic coronarysyndromes referred for clinically indicated ABCDE-SE, with dipyridamole (n = 1207), dobutamine (n = 84), or treadmillexercise (n = 1). Pulmonary congestion was evaluated with lung ultrasound and a 4-site simplified scan. Same day valuesof 4 pollutants were obtained on the morning of testing (average of 6 h) from publicly available data sets of the regionalauthority of environmental protection. Assessment of air pollution included fine (< 2.5 ?m diameter) and coarse (< 10 ?m)particulate matter (PM), ozone and nitrogen dioxide (NO 2 ).NO 2 concentration was weakly correlated with rest (r = .089; p = 0.001) and peak stress B-lines (r = .099; p < 0.001). A mul-tivariable logistic regression analysis, NO2 values above the median (23.1 ?g/m 3) independently predicted stress B-lines withodds ratio = 1.480 (95% CI 1.118-1.958) together with age, hypertension, diabetes, and reduced (< 50%) ejection fraction.PM 2.5 values were higher in 249 patients with compared to those without B-lines (median and IQR, 22.0 [9.1-23.5] vs 17.6[8.6-22.2] ?g/m 3 , p < 0.001). No other pollutant correlated with other (A-C-D-E) SE steps.Higher concentration of NO 2 is associated with more pulmonary congestion mirrored by B-lines at lung ultrasound. Localinflammation mediated by NO 2 well within legally allowed limits may increase the permeability of the alveolar-capillarybarrier and therefore pulmonary congestion in susceptible subjects

Nitrogen dioxide component of air pollution increases pulmonary congestion assessed by lung ultrasound in patients with chronic coronary syndromes

Cristina Mangia;Eugenio Picano
2022

Abstract

Pulmonary congestion is an intermediate biomarker and long-term predictor of acute decompensated heart failure.To evaluate the effects of air pollution on pulmonary congestion assessed by lung ultrasound.In a single-center, prospective, observational study design, we enrolled 1292 consecutive patients with chronic coronarysyndromes referred for clinically indicated ABCDE-SE, with dipyridamole (n = 1207), dobutamine (n = 84), or treadmillexercise (n = 1). Pulmonary congestion was evaluated with lung ultrasound and a 4-site simplified scan. Same day valuesof 4 pollutants were obtained on the morning of testing (average of 6 h) from publicly available data sets of the regionalauthority of environmental protection. Assessment of air pollution included fine (< 2.5 ?m diameter) and coarse (< 10 ?m)particulate matter (PM), ozone and nitrogen dioxide (NO 2 ).NO 2 concentration was weakly correlated with rest (r = .089; p = 0.001) and peak stress B-lines (r = .099; p < 0.001). A mul-tivariable logistic regression analysis, NO2 values above the median (23.1 ?g/m 3) independently predicted stress B-lines withodds ratio = 1.480 (95% CI 1.118-1.958) together with age, hypertension, diabetes, and reduced (< 50%) ejection fraction.PM 2.5 values were higher in 249 patients with compared to those without B-lines (median and IQR, 22.0 [9.1-23.5] vs 17.6[8.6-22.2] ?g/m 3 , p < 0.001). No other pollutant correlated with other (A-C-D-E) SE steps.Higher concentration of NO 2 is associated with more pulmonary congestion mirrored by B-lines at lung ultrasound. Localinflammation mediated by NO 2 well within legally allowed limits may increase the permeability of the alveolar-capillarybarrier and therefore pulmonary congestion in susceptible subjects
2022
Istituto di Fisiologia Clinica - IFC
Istituto di Scienze dell'Atmosfera e del Clima - ISAC
air pollution
Coronary artery disease
Heart failure
Stress echocardiography
File in questo prodotto:
File Dimensione Formato  
s11356-021-17941-1.pdf

accesso aperto

Descrizione: Nitrogen dioxide component of air pollution increases pulmonary congestion assessed by lung ultrasound in patients with chronic coronary syndromes
Tipologia: Versione Editoriale (PDF)
Licenza: Creative commons
Dimensione 961.13 kB
Formato Adobe PDF
961.13 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.14243/415863
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact